A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME)

NCT03666923 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Retinopathy
Diabetic Macular Edema

Interventions

DRUG: THR-687 dose level 1
DRUG: THR-687 dose level 2
DRUG: THR-687 dose level 3

Sponsor

ThromboGenics